ARCHIVES

FDA Approves Imaging Agent For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

October 21, 1988

Funding Mechanisms: How They Are Used

August 12, 1983

Vanderbilt-Ingram Wins NCI SPORE Grant

April 19, 2002

Two-Month Longer Survival Found With Gliadel Wafer

March 31, 2006

NCI Official Says Public Health Issue As Important As Data In Mammography

April 2, 1993

Upton Wraps Up Reorganization – DCCR Revamped, No Prevention Division

October 12, 1979